Adeno-associated virus 2 infection in children with non-A–E hepatitis

Abstract

An outbreak of acute hepatitis of unknown aetiology in children was reported in Scotland1 in April 2022 and has now been identified in 35 countries2. Several recent studies have suggested an association with human adenovirus with this outbreak, a virus not commonly associated with hepatitis. Here we report a detailed case–control investigation and find an association between adeno-associated virus 2 (AAV2) infection and host genetics in disease susceptibility. Using next-generation sequencing, PCR with reverse transcription, serology and in situ hybridization, we detected recent infection with AAV2 in plasma and liver samples in 26 out of 32 (81%) cases of hepatitis compared with 5 out of 74 (7%) of samples from unaffected individuals. Furthermore, AAV2 was detected within ballooned hepatocytes alongside a prominent T cell infiltrate in liver biopsy samples. In keeping with a CD4+ T-cell-mediated immune pathology, the human leukocyte antigen (HLA) class II HLA-DRB1*04:01 allele was identified in 25 out of 27 cases (93%) compared with a background frequency of 10 out of 64 (16%; P = 5.49 × 10−12). In summary, we report an outbreak of acute paediatric hepatitis associated with AAV2 infection (most likely acquired as a co-infection with human adenovirus that is usually required as a ‘helper virus’ to support AAV2 replication) and disease susceptibility related to HLA class II status. A case–control study investigating the causes of recent cases of acute hepatitis of unknown aetiology in 32 children identifies an association between adeno-associated virus infection and host genetics in disease susceptibility.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 39

1. 1.

   Marsh K, et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill. 2022.

   Not in our library10.2807/1560-7917.es.2022.27.15.2200318

2. 2.

   Severe acute hepatitis of unknown aetiology in children—multi-country. 2022.

   Not in our library

3. 3.

   Investigation into Acute Hepatitis of Unknown Aetiology in Children in England Technical Briefing 4. 2022.

   Not in our library

4. 4.

   Gutierrez Sanchez LH, et al. A case series of children with acute hepatitis and human adenovirus infection. N Engl J Med. 2022.

   Not in our library10.1056/nejmoa2206294

5. 5.

   Karpen SJ. Acute hepatitis in children in 2022—human adenovirus 41? N Engl J Med. 2022.

   Not in our library10.1056/nejme2208409

6. 6.

   Kelgeri C, et al. Clinical spectrum of children with acute hepatitis of unknown cause. N Engl J Med. 2022.

   Not in our library10.1056/nejmoa2206704

7. 7.

   Dunning JW, et al. Open source clinical science for emerging infections. Lancet Infect Dis. 2014;14:8-9.

   Not in our library10.1016/s1473-3099(13)70327-x

8. 8.

   Knodell RG, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-435.

   Not in our library10.1002/hep.1840010511

9. 9.

   Krishna M. Histological grading and staging of chronic hepatitis. Clin Liver Dis. 2021;17:222-226.

   Not in our library10.1002/cld.1014

10. 10.

    Hsu HL, et al. Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties. Nat Commun. 2020;11:3279.

    Not in our library10.1038/s41467-020-17047-1

11. 11.

    Enhanced Surveillance of Covid-19 in Scotland (Population-based seroprevalence)—5 Week Rolling Estimate. 2022.

    Not in our library10.1016/j.puhe.2020.11.014

12. 12.

    Rodriguez-Inigo E, et al. Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels. J Mol Diagn. 2005;7:535-543.

    Not in our library10.1016/s1525-1578(10)60585-5

13. 13.

    Tomlinson JE, et al. Tropism, pathology, and transmission of equine parvovirus-hepatitis. Emerg Microbes Infect. 2020;9:651-663.

    Not in our library10.1080/22221751.2020.1741326

14. 14.

    Srivastava A, Lusby EW, Berns KI. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol. 1983;45:555-564.

    Not in our library10.1128/jvi.45.2.555-564.1983

15. 15.

    Atchison RW, Casto BC, Hammon WM. Adenovirus-associated defective virus particles. Science. 1965;149:754-756.

    Not in our library10.1126/science.149.3685.754

16. 16.

    Li C, et al. Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia. Gene Ther. 2012;19:288-294.

    Not in our library10.1038/gt.2011.90

17. 17.

    Martino AT, et al. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. Blood. 2013;121:2224-2233.

    Not in our library10.1182/blood-2012-10-460733

18. 18.

    Manno CS, et al. Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat Med. 2006;12:342-347.

    Not in our library10.1038/nm1358

19. 19.

    Mingozzi F, et al. CD8+ T-cell responses to adeno-associated virus capsid in humans. Nat Med. 2007;13:419-422.

    Not in our library10.1038/nm1549

20. 20.
    Immunogenicity and toxicity of AAV gene therapy · 2022

    No notice
21. 21.

    Chowdary P, et al. Phase 1–2 trial of AAVS3 gene therapy in patients with hemophilia B. N Engl J Med. 2022;387:237-247.

    Not in our library10.1056/nejmoa2119913

22. 22.

    Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in autoimmune liver disease—clinical and diagnostic relevance. Front Immunol. 2018;9:609.

    Not in our library10.3389/fimmu.2018.00609

23. 23.

    Rafie K, et al. The structure of enteric human adenovirus 41—a leading cause of diarrhea in children. Sci Adv. 2021;7:eabe0974.

    Not in our library10.1126/sciadv.abe0974

24. 24.

    Echavarria M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev. 2008;21:704-715.

    Not in our library10.1128/cmr.00052-07

25. 25.

    Baker JM, et al. Acute hepatitis and adenovirus infection among children—Alabama, October 2021–February 2022. MMWR Morb Mortal Wkly Rep. 2022;71:638-640.

    Not in our library10.15585/mmwr.mm7118e1

26. 26.

    Cooper S, et al. Long COVID-19 liver manifestation in children. J Pediatr Gastroenterol Nutr. 2022.

    Not in our library10.1097/mpg.0000000000003521

27. 27.

    Deep A, Grammatikopoulos T, Heaton N, Verma A, Dhawan A. Outbreak of hepatitis in children: clinical course of children with acute liver failure admitted to the intensive care unit. Intensive Care Med. 2022.

    Not in our library10.1007/s00134-022-06765-3

28. 28.

    van Gerven NM, et al. HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1. Genes Immun. 2015;16:247-252.

    Not in our library10.1038/gene.2014.82

29. 29.

    Lanchbury JS, et al. Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty’s syndrome. Hum Immunol. 1991;32:56-64.

    Not in our library10.1016/0198-8859(91)90117-r

30. 30.

    Gay D, et al. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature. 1987;328:626-629.

    Not in our library10.1038/328626a0

31. 31.

    Aurnhammer C, et al. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Hum Gene Ther Methods. 2012;23:18-28.

    Not in our library10.1089/hgtb.2011.034

32. 32.

    Tong L, et al. Discovery of RNA and DNA viruses using next-generation sequencing: metagenomics. 2023.

    Not in our library10.17504/protocols.io.261ge34zol47/v1

33. 33.

    van Maarseveen NM, Wessels E, de Brouwer CS, Vossen AC, Claas EC. Diagnosis of viral gastroenteritis by simultaneous detection of Adenovirus group F, Astrovirus, Rotavirus group A, Norovirus genogroups I and II, and Sapovirus in two internally controlled multiplex real-time PCR assays. J Clin Virol. 2010;49:205-210.

    Not in our library10.1016/j.jcv.2010.07.019

34. 34.

    Tong L, et al. Discovery of RNA and DNA viruses using next-generation sequencing: targeted enrichment. 2023.

    Not in our library10.17504/protocols.io.36wgqj3q3vk5/v1

35. 35.

    La Bella T, et al. Adeno-associated virus in the liver: natural history and consequences in tumour development. Gut. 2020;69:737-747.

    Not in our library10.1136/gutjnl-2019-318281

36. 36.
    QuPath: Open source software for digital pathology image analysis · 2017

    No notice
37. 37.

    Pairo-Castineira E, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92-98.

    Not in our library10.1038/s41586-020-03065-y

38. 38.

    Pappas DJ, Marin W, Hollenbach JA, Mack SJ. Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): an integrated case–control analysis pipeline. Hum Immunol. 2016;77:283-287.

    Not in our library10.1016/j.humimm.2015.12.006

39. 39.

    Gautheret-Dejean A, et al. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods. 2002;100:27-35.

    Not in our library10.1016/s0166-0934(01)00390-1

Cited by papers we hold 1

• Adeno-associated virus as a delivery vector for gene therapy of human diseases · 2024
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.